Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care

Heart

Volumn 102, Issue 24, 2016, Pages 1957-1962

  Emanuel, G ^a   Charlton, J ^a   Ashworth, M ^a   Gulliford, M C ^a,b   Dregan, A ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SMOKING; ADVERSE EFFECTS; AGED; ARTHRITIS, RHEUMATOID; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; CHRONIC DISEASE; CLINICAL PRACTICE; DYSLIPIDEMIAS; ELECTRONIC HEALTH RECORD; ENGLAND; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVENTION AND CONTROL; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; PROTOCOL COMPLIANCE; RISK FACTOR; SMOKING CESSATION; TIME FACTOR; TRENDS; URBAN HEALTH;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ARTHRITIS, RHEUMATOID; BIOMARKERS; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL; CHRONIC DISEASE; DYSLIPIDEMIAS; ELECTRONIC HEALTH RECORDS; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; INCIDENCE; INFLAMMATORY BOWEL DISEASES; LONDON; MALE; MIDDLE AGED; OBESITY; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; SMOKING CESSATION; TIME FACTORS; URBAN HEALTH;

EID: 84983509040     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2016-310111     Document Type: Article

References (18)

1. Kaplan MJ. Management of cardiovascular disease risk in chronic inflammatory disorders. Nat Rev Rheumatol 2009; 5: 208-17
2. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408-15
3. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005; 52: 402-11
4. Corrado E, Rizzo M, Coppola G, et al. An update on the role of markers of inflammation in atherosclerosis. J Atheroscl Thrombosis 2010; 17: 1-11
5. Dregan A, Charlton J, Chowienczyk P, et al. Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study. Circulation 2014; 130: 837-44
6. NICE. Rheumatoid arthritis in adults: management. Secondary Rheumatoid arthritis in adults: management. UK: National Institute for Clinical Excellence, 2009
7. Palmer D, El Miedany Y. From guidelines to clinical practice: cardiovascular risk management in inflammatory arthritis patients. Br J Community Nurs 2013; 18: 424-8
8. McErlane F, Gillon C, Irvine T, et al. Arthropathy in paediatric inflammatory bowel disease: a cross-sectional observational study. Rheumatology (Oxford) 2008; 47: 1251-2
9. Bartels CM, Kind AJ, Everett C, et al. Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis. Arthritis Rheum 2011; 63: 1221-30
10. Alemao E, Cawston H, Bourhis F, et al. Cardiovascular risk factor management in patients with RA compared to matched non-RA patients. Rheumatology (Oxford) 2016; 55: 809-16
11. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007; 335: 136
12. Corrales A, González-Juanatey C, Peiró ME, et al. Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis 2014; 73: 722-7
13. Corrales A, Parra JA, González-Juanatey C, et al. Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis 2013; 72: 1764-70
14. Kristensen SL, Ahlehoff O, Lindhardsen J, et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death-A Danish nationwide cohort study. PLoS One 2013; 8: e56944
15. Monk HL, Muller S, Mallen CD, et al. Cardiovascular screening in rheumatoid arthritis: a cross-sectional primary care database study. BMC Fam Practice 2013; 14: 150
16. An J, Cheetham TC, Reynolds K, et al. Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting. Arthritis Care Res 2016; 68: 629-37
17. Gossec L, Salejan F, Nataf H, et al. Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients. Arthritis Care Res 2013; 65: 712-17
18. Desai SS, Myles JD, Kaplan MJ. Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis. Arthritis Res Therapy 2012; 14: R270